Literature DB >> 17537380

Epidemiological and ethical aspects of multiplex autoantibody testing.

Ettore Bidoli1, Danilo Villalta, M Battistin, E Bidoli, A Cammarota, M Ciccone, R Fedato, B Lodi, F Marchesini, G Molaro, E Ostardo, G Rellini, R Sartori, D Schinella.   

Abstract

Arrays are one of the technologies able to detect autoantibodies by measuring simultaneously many thousands of markers from a unique biological sample. The main purpose of a diagnostic test is making an early and accurate diagnosis. From a statistical point of view, multiple testing increases the probability of false positive and false negative results. Some correction methods are available to account for this problem for instance family-wise error rate or false discovery rate. From an ethical point of view, the decision to accept or decline a test not requested has to be made autonomously. Some people may seek clarification about tests and implications of their choices. A scarcity of proven measures to reduce mortality has to be considered too. Reasons may also include avoidance of psychological harm or anxiety. Moreover, protection of confidentiality and privacy has to be respected. In conclusion, the fact that testing is optional and that surveillance advice can be offered on the basis of risk alone without a test should be discussed in the consultation. The implication of a positive test result should be discussed to make a decision about the degree to which early treatment of the condition is better than late (or no) treatment.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17537380     DOI: 10.1016/j.autrev.2007.01.008

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  3 in total

Review 1.  The predictive significance of autoantibodies in organ-specific autoimmune diseases.

Authors:  Nicola Bizzaro
Journal:  Clin Rev Allergy Immunol       Date:  2008-06       Impact factor: 8.667

2.  Whither autoimmunity: the lessons of anti-CCP and B cell depletion.

Authors:  Yehuda Shoenfeld; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2008-02       Impact factor: 8.667

Review 3.  Detecting multiple autoantibodies to diagnose autoimmune co-morbidity (multiple autoimmune syndromes and overlap syndromes): a challenge for the autoimmunologist.

Authors:  Renato Tozzoli; Maria Concetta Sorrentino; Nicola Bizzaro
Journal:  Immunol Res       Date:  2013-07       Impact factor: 2.829

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.